| Cardiovascular Risk Management |
1 |
1 |
| Rheumatic Disease |
0 |
0.99 |
| Heart Failure (HF) |
0 |
0.5 |
| Cardiovascular disease |
0 |
0.37 |
| Systemic Lupus Erythematosus |
0 |
0.29 |
| Autoimmune Disease |
0 |
0.27 |
| Clinical Guidelines |
0 |
0.27 |
| Heart |
0 |
0.27 |
| Lupus |
0 |
0.27 |
| Systemic Sclerosis |
0 |
0.27 |
| Cardiomyopathy |
0 |
0.24 |
| Scleroderma |
0 |
0.23 |
| Arrhythmia |
0 |
0.21 |
| Atrial Fibrillation |
0 |
0.21 |
| Europe |
0 |
0.16 |
| Cerebrovascular Accident |
0 |
0.12 |
| Blood |
0 |
0.11 |
| Blood Vessel |
0 |
0.11 |
| Primary Care |
0 |
0.11 |
| Risk Management |
0 |
0.11 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.1 |
| Obesity |
0 |
0.09 |
| Peripheral Artery Disease |
0 |
0.08 |
| Infective Endocarditis |
0 |
0.07 |
| Rheumatoid Arthritis |
0 |
0.07 |
| Aneurysm |
0 |
0.05 |
| Ankylosing Spondylitis |
0 |
0.05 |
| Arthritis |
0 |
0.05 |
| Electronic Health Record (EHR) |
0 |
0.05 |
| Electronic Medical Record |
0 |
0.05 |
| Endocarditis |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Intellectual Property |
0 |
0.05 |
| Match |
0 |
0.05 |
| Medical Innovations |
0 |
0.05 |
| Myocarditis |
0 |
0.05 |
| Pericarditis |
0 |
0.05 |
| Polymyalgia Rheumatica |
0 |
0.05 |
| Transient Ischemic Attack |
0 |
0.05 |
| Vasculitis |
0 |
0.05 |